Dalpiciclib partially abrogates ER signaling activation induced by pyrotinib in HER2+HR+ breast cancer
Jiawen Bu(China Medical University), Caigang Liu(Dalian Medical University)
Cited by 17
Related Papers
Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients
|Oncotarget|2014|160
Nestin positively regulates the Wnt/β-catenin pathway and the proliferation, survival and invasiveness of breast cancer stem cells
|Breast Cancer Research|2014|146
CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer
|Molecular Cancer|2023|50
Targeting SOST using a small-molecule compound retards breast cancer bone metastasis
|Molecular Cancer|2022|35